New York Oncology Hematology,P.C.-Albany — Albany, New York

New York Oncology Hematology,P.C.-Albany is a clinical research site located in Albany, New York, United States 12208.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

New York Oncology Hematology,P.C.-Albany has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Lung Cancer (NSCLC), Carcinoma, Renal Cell, Triple Negative Breast Neoplasms.

Sponsors: Hoffmann-La Roche, EMD Serono Research & Development Institute, Inc., Celcuity Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Albany

Browse all research sites in New York · View every site in Albany

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology,P.C.-Albany?

New York Oncology Hematology,P.C.-Albany has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology,P.C.-Albany conducted?

New York Oncology Hematology,P.C.-Albany has 5 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer (NSCLC), Carcinoma, Renal Cell, Triple Negative Breast Neoplasms.

Is New York Oncology Hematology,P.C.-Albany accredited by Crixeo Clinical Trials?

New York Oncology Hematology,P.C.-Albany has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology,P.C.-Albany?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.